Cargando…

Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis

Control of the intracellular parasite Leishmania (L.) requires the activation of strong type 1 cellular immune responses. Towards this goal, in the present study, a multiepitope chimeric protein named LiChimera was encapsulated into cationic liposomes and its protective efficacy against experimental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agallou, Maria, Margaroni, Maritsa, Karagouni, Evdokia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459177/ https://www.ncbi.nlm.nih.gov/pubmed/37631952 http://dx.doi.org/10.3390/vaccines11081384

Ejemplares similares

A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with Leishmania infantum
por: Agallou, Maria, et al.
Publicado: (2020)

Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses
por: Margaroni, Maritsa, et al.
Publicado: (2023)

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis
por: Margaroni, Maritsa, et al.
Publicado: (2017)

Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine
por: Agallou, Maria, et al.
Publicado: (2017)

Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice
por: Agallou, Maria, et al.
Publicado: (2019)

Transcriptional Profiling of Leishmania infantum Infected Dendritic Cells: Insights into the Role of Immunometabolism in Host-Parasite Interaction
por: Margaroni, Maritsa, et al.
Publicado: (2022)

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
por: Agallou, Maria, et al.
Publicado: (2014)

Development of a Nanoparticle-based Lateral Flow Strip Biosensor for Visual Detection of Whole Nervous Necrosis Virus Particles
por: Toubanaki, Dimitra K., et al.
Publicado: (2020)

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8(+) T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
por: Athanasiou, Evita, et al.
Publicado: (2017)

Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2
por: Agallou, Maria, et al.
Publicado: (2022)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis
por: Shivahare, Rahul, et al.
Publicado: (2014)

Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis
por: Agallou, Maria, et al.
Publicado: (2016)

Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
por: Collin, Nicolas, et al.
Publicado: (2009)

Towards A Novel Multi-Epitopes Chimeric Vaccine for Simulating Strong Immune Responses and Protection against Morganella morganii
por: Ullah, Asad, et al.
Publicado: (2021)

Development of a Multi-Epitope Recombinant Protein for the Diagnosis of Human Visceral Leishmaniasis
por: JAMEIE, Farnoosh, et al.
Publicado: (2021)

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS
por: ROSSI, Claudio Nazaretian, et al.
Publicado: (2016)

Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
por: García-Castro, Ana, et al.
Publicado: (2022)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2016)

Immune Regulation during Chronic Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2014)

A T-Cell Epitope-Based Multi-Epitope Vaccine Designed Using Human HLA Specific T Cell Epitopes Induces a Near-Sterile Immunity against Experimental Visceral Leishmaniasis in Hamsters
por: Arya, Aryandra, et al.
Publicado: (2021)

Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2019)

VCAM-1 and ICAM-1 Serum Levels as Markers of Relapse in Visceral Leishmaniasis
por: Makis, Alexandros, et al.
Publicado: (2017)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis
por: Lage, Daniela P., et al.
Publicado: (2020)

Visceral Leishmaniasis Revealing Undiagnosed Inborn Errors of Immunity
por: Carvalho, Daniel Gleison, et al.
Publicado: (2023)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019)

Immunoinformatics Studies and Design of a Potential Multi-Epitope Peptide Vaccine to Combat the Fatal Visceral Leishmaniasis
por: Onile, Olugbenga Samson, et al.
Publicado: (2022)

One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis
por: Costa-Pereira, Christiane, et al.
Publicado: (2015)

Adenosine and Immune Imbalance in Visceral Leishmaniasis: The Possible Role of Ectonucleotidases
por: Paletta-Silva, Rafael, et al.
Publicado: (2012)

The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis
por: de Freitas, Elisangela Oliveira, et al.
Publicado: (2016)

Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis
por: Moreno, Javier
Publicado: (2019)

Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

Induction of innate immune responses by KPC-producing Klebsiella pneumoniae of the pandemic sequence type 258-clade I
por: Balaska, Asimina, et al.
Publicado: (2021)

Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis
por: Costa, Sidnei Ferro, et al.
Publicado: (2020)

Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2012)

Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis
por: Lima Maciel, Bruna L., et al.
Publicado: (2014)

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection
por: Lage, Daniela P., et al.
Publicado: (2020)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hnett5j11a3cv3o1q0hn4u6r7e